Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare aggressive malignancy with poor outcomes. Although novel options like tagraxofusp, a CD123-directed cytotoxin, has emerged and is promising, treatment options are very limited in the relapsed and recurrent setting. We present a case of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashok Kumar, Prashanth, Ombada, Mulham, Pemmasani, Gayatri, Tambe, Ajay, Banki, Katalin, Gentile, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638685/
https://www.ncbi.nlm.nih.gov/pubmed/36341907
http://dx.doi.org/10.1177/23247096221127114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638685/
https://www.ncbi.nlm.nih.gov/pubmed/36341907
http://dx.doi.org/10.1177/23247096221127114

Ejemplares similares